Abstract: The present invention relates to crystalline form II of memantine hydrochloride Memantine hydrochloride is used in the treatment of Alzheimer's & Parkinson's disease.
| # | Name | Date |
|---|---|---|
| 1 | 1258-mum-2003-form 2(title page)-(10-12-2003).pdf | 2003-12-10 |
| 2 | 1258-mum-2003-form 2(provisional)-(10-12-2003).pdf | 2003-12-10 |
| 3 | 1258-mum-2003-form 1(10-12-2003).pdf | 2003-12-10 |
| 4 | 1258-mum-2003-drawing(provisional)-(10-12-2003).pdf | 2003-12-10 |
| 5 | 1258-mum-2003-description(provisional)-(10-12-2003).pdf | 2003-12-10 |
| 6 | 1258-mum-2003-form 1(23-12-2003).pdf | 2003-12-23 |
| 7 | 1258-mum-2003-form 2(title page)-(10-12-2004).pdf | 2004-12-10 |
| 8 | 1258-mum-2003-form 2(10-12-2004).pdf | 2004-12-10 |
| 9 | 1258-mum-2003-drawing(10-12-2004).pdf | 2004-12-10 |
| 10 | 1258-mum-2003-description(complete)-(10-12-2004).pdf | 2004-12-10 |
| 11 | 1258-mum-2003-claims(10-12-2004).pdf | 2004-12-10 |
| 12 | 1258-mum-2003-abstract(10-12-2004).pdf | 2004-12-10 |
| 13 | 1258-mum-2003-form 18(19-11-2007).pdf | 2007-11-19 |
| 14 | 1258-mum-2003-correspondence 1(19-11-2007).pdf | 2007-11-19 |
| 15 | 1258-MUM-2003_EXAMREPORT.pdf | 2018-08-08 |
| 16 | 1258-MUM-2003-PUBLICATION REPORT(11-9-2008).pdf | 2018-08-08 |
| 17 | 1258-mum-2003-correspondence(ipo)-(16-7-2009).pdf | 2018-08-08 |
| 18 | 1258-mum-2003-correspondence(ipo)-(11-5-2011).pdf | 2018-08-08 |
| 19 | 1258-MUM-2003-CORRESPONDENCE(11-9-2008).pdf | 2018-08-08 |
| 20 | 1258-mum-2003-correspondence 2(22-7-2009).pdf | 2018-08-08 |